Clinical Response and Remission in Patients With Severe Asthma Treated With Biologic TherapiesSusanne Hansen, Celeste Porsbjerg, Anne‐Sofie Bjerrum et al.|CHEST Journal|2023Cited by 139
The impact of biologic therapy on work capacity and workforce attachment in patients with severe asthmaKjell Erik Julius Håkansson, Celeste Porsbjerg, Niels Steen Krogh et al.|Journal of Asthma|2025Cited by 3
Late Breaking Abstract - The impact of biologic therapy on work capacity and workforce withdrawal in severe asthmaKjell Erik Julius Håkansson, Celeste Porsbjerg, Niels Steen Krogh et al.|Epidemiology|2024Cited by 0
Reduction in FeNO on anti-IL5 biologics is associated with clinical remission of severe asthmaMarianne Baastrup Soendergaard, Celeste Porsbjerg, Anna von Bülow et al.|Unknown|2024Cited by 0
Long-term Reduction in Inhaled and Systemic Corticosteroid Exposure During Anti-interleukin 5 Therapy for Severe Asthma – A Nationwide Study from the Danish Severe Asthma RegistryKåre Håkansson, Celeste Porsbjerg, Anna von Bülow et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 0